IL244810A0 - Stabilized polypeptides and their uses - Google Patents
Stabilized polypeptides and their usesInfo
- Publication number
- IL244810A0 IL244810A0 IL244810A IL24481016A IL244810A0 IL 244810 A0 IL244810 A0 IL 244810A0 IL 244810 A IL244810 A IL 244810A IL 24481016 A IL24481016 A IL 24481016A IL 244810 A0 IL244810 A0 IL 244810A0
- Authority
- IL
- Israel
- Prior art keywords
- stabilized polypeptides
- polypeptides
- stabilized
- Prior art date
Links
- 229920001184 polypeptide Polymers 0.000 title 1
- 102000004196 processed proteins & peptides Human genes 0.000 title 1
- 108090000765 processed proteins & peptides Proteins 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
- C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
- C07K14/4702—Regulators; Modulating activity
- C07K14/4705—Regulators; Modulating activity stimulating, promoting or activating activity
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C229/00—Compounds containing amino and carboxyl groups bound to the same carbon skeleton
- C07C229/02—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton
- C07C229/30—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and unsaturated
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Gastroenterology & Hepatology (AREA)
- Zoology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Molecular Biology (AREA)
- Genetics & Genomics (AREA)
- Biophysics (AREA)
- Biochemistry (AREA)
- Toxicology (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- General Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201361885384P | 2013-10-01 | 2013-10-01 | |
| US201461934618P | 2014-01-31 | 2014-01-31 | |
| PCT/US2014/058680 WO2015051030A2 (en) | 2013-10-01 | 2014-10-01 | Stabilized polypeptides and uses thereof |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IL244810A0 true IL244810A0 (en) | 2016-05-31 |
Family
ID=52779285
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL244810A IL244810A0 (en) | 2013-10-01 | 2016-03-29 | Stabilized polypeptides and their uses |
Country Status (6)
| Country | Link |
|---|---|
| US (1) | US20160244494A1 (OSRAM) |
| EP (1) | EP3052520A4 (OSRAM) |
| JP (1) | JP2017503749A (OSRAM) |
| CN (1) | CN106103472A (OSRAM) |
| IL (1) | IL244810A0 (OSRAM) |
| WO (1) | WO2015051030A2 (OSRAM) |
Families Citing this family (26)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7192713B1 (en) | 1999-05-18 | 2007-03-20 | President And Fellows Of Harvard College | Stabilized compounds having secondary structure motifs |
| CA2677045C (en) | 2007-01-31 | 2016-10-18 | Dana-Farber Cancer Institute, Inc. | Stabilized p53 peptides and uses thereof |
| KR101623985B1 (ko) | 2007-03-28 | 2016-05-25 | 프레지던트 앤드 펠로우즈 오브 하바드 칼리지 | 스티칭된 폴리펩티드 |
| KR102104762B1 (ko) | 2010-08-13 | 2020-04-24 | 에일러론 테라퓨틱스 인코포레이티드 | 펩티도미메틱 거대고리 |
| CN108929375A (zh) | 2011-10-18 | 2018-12-04 | 爱勒让治疗公司 | 拟肽大环化合物 |
| EP2819688A4 (en) | 2012-02-15 | 2015-10-28 | Aileron Therapeutics Inc | PEPTIDOMIMETIC MACROCYCLES CROSS-LINKED WITH TRIAZOLE AND THIOETHER |
| KR102112373B1 (ko) | 2012-02-15 | 2020-05-18 | 에일러론 테라퓨틱스 인코포레이티드 | 펩티드모방체 마크로사이클 |
| WO2014138429A2 (en) | 2013-03-06 | 2014-09-12 | Aileron Therapeutics, Inc. | Peptidomimetic macrocycles and use thereof in regulating hif1alpha |
| CA2931547A1 (en) | 2013-12-09 | 2015-06-18 | Durect Corporation | Pharmaceutically active agent complexes, polymer complexes, and compositions and methods involving the same |
| SG10201902598VA (en) | 2014-09-24 | 2019-04-29 | Aileron Therapeutics Inc | Peptidomimetic macrocycles and formulations thereof |
| CN106999541A (zh) | 2014-09-24 | 2017-08-01 | 艾瑞朗医疗公司 | 拟肽大环化合物及其用途 |
| MX2017011834A (es) | 2015-03-20 | 2018-04-11 | Aileron Therapeutics Inc | Macrociclos peptidomimeticos y usos de los mismos. |
| WO2017004548A1 (en) | 2015-07-01 | 2017-01-05 | Aileron Therapeutics, Inc. | Peptidomimetic macrocycles |
| CN110114075B (zh) | 2016-11-09 | 2024-01-12 | 俄亥俄州国家创新基金会 | 含有二硫化物的细胞穿透肽及其制备和使用方法 |
| WO2018098282A2 (en) * | 2016-11-22 | 2018-05-31 | Ohio State Innovation Foundation | Cyclic cell penetrating peptides comprising beta-hairpin motifs and methods of making and using thereof |
| WO2018098226A1 (en) | 2016-11-22 | 2018-05-31 | Ohio State Innovation Foundation | Bicyclic peptidyl inhibitor of tumor necrosis factor-alpha |
| JP2020533413A (ja) | 2017-09-07 | 2020-11-19 | フォグ ファーマシューティカルズ, インコーポレイテッド | ベータ−カテニンの機能を調節する薬剤及びその方法 |
| WO2019070962A1 (en) | 2017-10-04 | 2019-04-11 | Ohio State Innovation Foundation | BICYCLIC PEPTIDE INHIBITORS |
| WO2019118893A1 (en) | 2017-12-15 | 2019-06-20 | Dana-Farber Cancer Institute, Inc. | Stabilized peptide-mediated targeted protein degradation |
| WO2019136209A1 (en) * | 2018-01-05 | 2019-07-11 | President And Fellows Of Harvard College | Stabilized polypeptides and uses thereof |
| US11793884B2 (en) | 2018-01-29 | 2023-10-24 | Ohio State Innovation Foundation | Cyclic peptidyl inhibitors of CAL-PDZ binding domain |
| EP3749678A1 (en) | 2018-02-07 | 2020-12-16 | Dana Farber Cancer Institute, Inc. | Cell-permeable stapled peptide modules for cellular delivery |
| EP3790890A4 (en) | 2018-05-09 | 2022-03-02 | Ohio State Innovation Foundation | CYCLIC PEPTIDES OF CELL PENETRATION WITH ONE OR MORE HYDROPHOBIC RESIDUES |
| WO2020023502A1 (en) | 2018-07-23 | 2020-01-30 | Aileron Therapeutics, Inc. | Peptidomimetic macrocycles and uses thereof |
| EP3840766A4 (en) | 2018-08-20 | 2022-06-22 | Fog Pharmaceuticals, Inc. | Collections of peptides, peptide agents, and methods of use thereof |
| US20230174576A1 (en) * | 2020-10-30 | 2023-06-08 | Xeno-Interface Inc. | Beta-strand bridge peptide |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1282722B1 (en) * | 1999-10-15 | 2011-06-15 | Avatar Medical, L.L.C. | Stabilized proteins |
| WO2005044839A2 (en) * | 2003-11-05 | 2005-05-19 | Dana-Farber Cancer Institute, Inc. | Stabilized alpha helical peptides and uses thereof |
| JP5553954B2 (ja) * | 2003-11-15 | 2014-07-23 | ポリファー リミテッド | テンプレート固定β−ヘアピンループ模倣体とそのファージディスプレイにおける使用 |
| WO2005118620A2 (en) * | 2004-05-27 | 2005-12-15 | New York University | Methods for preparing internally constraied peptides and peptidomimetics |
| WO2006069001A2 (en) * | 2004-12-20 | 2006-06-29 | Baylor College Of Medicine | Structural requirements for stat3 binding and recruitment to phosphototyrosine ligands |
| KR101623985B1 (ko) * | 2007-03-28 | 2016-05-25 | 프레지던트 앤드 펠로우즈 오브 하바드 칼리지 | 스티칭된 폴리펩티드 |
| WO2010011313A2 (en) * | 2008-07-23 | 2010-01-28 | President And Fellows Of Harvard College | Ligation of stapled polypeptides |
| CA2768299C (en) * | 2009-07-13 | 2018-03-20 | President And Fellows Of Harvard College | Bifunctional stapled polypeptides and uses thereof |
| US20130177979A1 (en) * | 2010-06-22 | 2013-07-11 | University Of Central Florida Research Foundation, Inc. | Methods and compositions for cell permeable stat3 inhibitor |
-
2014
- 2014-10-01 US US15/026,473 patent/US20160244494A1/en not_active Abandoned
- 2014-10-01 WO PCT/US2014/058680 patent/WO2015051030A2/en not_active Ceased
- 2014-10-01 EP EP14850442.6A patent/EP3052520A4/en not_active Withdrawn
- 2014-10-01 JP JP2016519779A patent/JP2017503749A/ja active Pending
- 2014-10-01 CN CN201480065507.3A patent/CN106103472A/zh active Pending
-
2016
- 2016-03-29 IL IL244810A patent/IL244810A0/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| US20160244494A1 (en) | 2016-08-25 |
| WO2015051030A8 (en) | 2015-05-07 |
| EP3052520A4 (en) | 2017-12-06 |
| EP3052520A2 (en) | 2016-08-10 |
| CN106103472A (zh) | 2016-11-09 |
| WO2015051030A3 (en) | 2015-06-25 |
| JP2017503749A (ja) | 2017-02-02 |
| WO2015051030A2 (en) | 2015-04-09 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL276106A (en) | Garp-binding proteins and their uses | |
| IL274355B (en) | Aza-pyridone compounds and their uses | |
| IL244810A0 (en) | Stabilized polypeptides and their uses | |
| IL261547B (en) | Antibodies against pesidine and their uses | |
| GB201311475D0 (en) | Polypeptides | |
| IL245040A0 (en) | Antibodies against pdgfr-beta and their uses | |
| ZA201505705B (en) | Phi-4 polypeptides and methods for their use | |
| IL243974B (en) | Antibodies against –prlr and uses | |
| IL244850A0 (en) | Stabilized epinaconazole preparations, and their uses | |
| IL240606A0 (en) | New polypeptides | |
| IL240393A0 (en) | Il-33 antagonists and their uses | |
| IL240354A0 (en) | Antibodies against il-33 and their uses | |
| EP2967081A4 (en) | Modified caspase polypeptides and uses thereof | |
| SG11201506876XA (en) | Modification of polypeptides | |
| SG11201602889TA (en) | Novel polypeptides | |
| GB201323008D0 (en) | Compounds and uses thereof | |
| PT3058936T (pt) | Composição peptídica e respetivos usos | |
| EP2988742A4 (en) | THIAZOLES AND USES THEREOF | |
| GB201307233D0 (en) | Compounds and uses thereof | |
| GB201320992D0 (en) | Complex and uses thereof | |
| ZA201601880B (en) | Hetero-transglycosylase and uses thereof | |
| GB201309421D0 (en) | Polypeptides | |
| PL3080276T3 (pl) | Polipeptydy toksyczne dla owadów | |
| ZA201506407B (en) | New polypeptides | |
| EP3006564A4 (en) | NEW PEPTIDE AND ITS USE |